Date
Title
View
21 Jan 20
4basebio AG: 4basebio AG decides to buy back 2 million treasury shares for further use in accordance with the authorizing resolution
View
11 Nov 19
Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business
View
29 Oct 19
Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019
View
14 Mar 19
Expedeon AG: Expedeon Announces Supervisory Board Changes
View
18 May 18
SYGNIS AG: SYGNIS raises revenue guidance for 2018 after closing the acquisition of TGR Biosciences
View
02 May 18
SYGNIS AG: – Sygnis obtains finance to close the acquisition of the Australian TGR Biosciences PTY LTD –
View
20 Mar 18
SYGNIS AG: SYGNIS AG raise approximately EUR 4.2 million in private placement
View
19 Mar 18
Correction of a release from 19.03.2018, 17:55 CET/CEST – SYGNIS AG: SYGNIS AG to raise capital via a private placement of new shares to acquire TGR Biosciences
View
19 Mar 18
SYGNIS AG: SYGNIS AG to raise capital via a private placement of new shares to acquire TGR Biosciences
View
05 Jun 17
SYGNIS AG: SYGNIS AG announces management changes
View
30 May 17
SYGNIS AG: SYGNIS AG successfully completes Rights Offering and Private Placement
View
24 May 17
SYGNIS AG: SYGNIS AG receives binding commitment for the purchase of shares for up to EUR 3.5 million within the scope of the ongoing capital increases to finance the acquisition of Innova Biosciences Ltd.
View